Extended Data Fig. 4: Efficient tumour rejection by anti-PD-L1 and anti-TIGIT mAbs treatment depends on functional Fc-FcɣR interaction axis. | Nature

Extended Data Fig. 4: Efficient tumour rejection by anti-PD-L1 and anti-TIGIT mAbs treatment depends on functional Fc-FcɣR interaction axis.

From: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

Extended Data Fig. 4

a, Plots depicting tumour volumes in each mouse over time; data are representative of one independent experiment. Wildtype BALB/c mice were implanted with CT26 tumours and then treated as described in the method. b, Plots depicting tumour volumes in each mouse over time; data are representative of one independent experiment. Wildtype (top) and FcɣR knockout (bottom) BALB/c mice were implanted with CT26 tumours and then treated as described in the method.

Source Data

Back to article page